{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T19:43:23Z","timestamp":1769888603153,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P01 DA032507"],"award-info":[{"award-number":["P01 DA032507"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM007750"],"award-info":[{"award-number":["T32 GM007750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1 TR002318"],"award-info":[{"award-number":["TL1 TR002318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.placenta.2025.12.012","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:08:09Z","timestamp":1766534889000},"page":"174-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Elucidating the role of ABC transporters in the placental efflux of (\u2212)- \u03949-tetrahydrocannabinol (THC) using a cocktail of ABC transport inhibitors"],"prefix":"10.1016","volume":"174","author":[{"given":"Ankit","family":"Balhara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan E.","family":"Wasickanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua W.","family":"Monson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Damicis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary J.","family":"Kinsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Ieronimakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-8455","authenticated-orcid":false,"given":"Jashvant D.","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.placenta.2025.12.012_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/ADM.0000000000000516","article-title":"Cannabis use based on urine drug screens in pregnancy and its association with infant birth weight","volume":"13","author":"Howard","year":"2019","journal-title":"J. Addiction Med."},{"key":"10.1016\/j.placenta.2025.12.012_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0041-008X(87)90338-3","article-title":"Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey","volume":"90","author":"Bailey","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.placenta.2025.12.012_bib3","first-page":"311","article-title":"Human placental transfer of cannabinoids. N. Engl","volume":"797","author":"Blackard","year":"1984","journal-title":"J. Med."},{"issue":"9","key":"10.1016\/j.placenta.2025.12.012_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.120.000067","article-title":"Gestational age-dependent abundance of human placental transporters as determined by quantitative targeted proteomics","volume":"48","author":"Anoshchenko","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2025.12.012_bib5","first-page":"S94","article-title":"Unadkat JD. Predicting human fetal drug exposure through maternal-fetal PBPK modeling and in vitro or Ex vivo studies","volume":"62","author":"Balhara","year":"2022","journal-title":"J. Clin. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.placenta.2025.12.012_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1369-1600.2008.00096.x","article-title":"Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein","volume":"13","author":"Bonhomme-Faivre","year":"2008","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.placenta.2025.12.012_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cpt.2964","article-title":"Understanding the mechanism and extent of transplacental transfer of (-)-\u03949 -Tetrahydrocannabinol (THC) in the perfused human placenta to predict in vivo fetal THC exposure","volume":"114","author":"Kumar","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.placenta.2025.12.012_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/dmd.121.000505","article-title":"Mao Q. Tetrahydrocannabinol and its major metabolites are not (or are poor) substrates or inhibitors of human P-Glycoprotein [ATP-binding cassette (ABC) B1] and breast cancer resistance protein (ABCG2)","volume":"49","author":"Chen","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.placenta.2025.12.012_bib9","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/jps.22566","article-title":"Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in vivo drug interactions","volume":"100","author":"Zolnerciks","year":"2011","journal-title":"J. Pharmaceut. Sci."},{"issue":"12","key":"10.1016\/j.placenta.2025.12.012_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082463","article-title":"Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1)","volume":"8","author":"Chufan","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.placenta.2025.12.012_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","article-title":"Communication between multiple drug binding sites on P-glycoprotein","volume":"58","author":"Martin","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.placenta.2025.12.012_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/dmd.108.022046","article-title":"Substrate-dependent breast cancer resistance protein (Bcrp1\/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design","volume":"37","author":"Giri","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.placenta.2025.12.012_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bcp.2014.10.006","article-title":"2019; Loo TW, Clarke DM. Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation","volume":"92","author":"Alam","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.placenta.2025.12.012_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149855","article-title":"Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules","volume":"709","author":"Hamaguchi-Suzuki","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.placenta.2025.12.012_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/(SICI)1097-0215(19980529)76:5<729::AID-IJC19>3.0.CO;2-Z","article-title":"Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment","volume":"76","author":"Jett\u00e9","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.placenta.2025.12.012_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport- an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"issue":"11","key":"10.1016\/j.placenta.2025.12.012_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0006-2952(01)00599-8","article-title":"Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells","volume":"61","author":"Green","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.012_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0271678X211045444","article-title":"Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: a criterion of choice?","volume":"42","author":"Breuil","year":"2022","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.placenta.2025.12.012_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-024-00562-4","article-title":"ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain","volume":"21","author":"Lentzas","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.placenta.2025.12.012_bib20","article-title":"SOLVO introducing PSC 833 the specific P- gp inhibitor and new drug transporter services","year":"2009","journal-title":"SOLVO Biotechnol."},{"issue":"6","key":"10.1016\/j.placenta.2025.12.012_bib21","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1007\/s00210-024-03743-y","article-title":"The \"specific\" P-glycoprotein inhibitor zosuquidar (LY335979) also weakly inhibits human organic cation transporters","volume":"398","author":"Bajraktari-Sylejmani","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"10.1016\/j.placenta.2025.12.012_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cn100078a","article-title":"The \"specific\" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP\/ABCG2)","volume":"2","author":"Kannan","year":"2011","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.placenta.2025.12.012_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1124\/jpet.115.225482","article-title":"The inhibitor Ko143 is not specific for ABCG2","volume":"354","author":"Weidner","year":"2015","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"8","key":"10.1016\/j.placenta.2025.12.012_bib24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"2","key":"10.1016\/j.placenta.2025.12.012_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0925-4439(97)00027-6","article-title":"Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.placenta.2025.12.012_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41467-025-55863-5","article-title":"Quantification and prediction of human fetal (-)-\u03949-tetrahydrocannabinol\/(\u00b1)-11-OH-\u03949-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity","volume":"16","author":"Kumar","year":"2025","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.placenta.2025.12.012_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212036","article-title":"Are \u03949-Tetrahydrocannabinol and its major metabolites substrates or inhibitors of placental or human hepatic drug solute-carrier transporters?","volume":"25","author":"Chen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.placenta.2025.12.012_bib28","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1124\/dmd.121.000538","article-title":"Successful prediction of human fetal exposure to P-Glycoprotein substrate drugs using the proteomics-informed relative expression factor approach and PBPK modeling and simulation","volume":"49","author":"Anoshchenko","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.placenta.2025.12.012_bib29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cpt.3157","article-title":"Successful prediction of fetal exposure to dual BCRP\/P-gp drug substrates using the efflux ratio-relative expression factor approach and PBPK M&S","volume":"5","author":"Balhara","year":"2024","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:22:29Z","timestamp":1769836949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425007726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"alternative-id":["S0143400425007726"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.12.012","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the role of ABC transporters in the placental efflux of (\u2212)- \u03949-tetrahydrocannabinol (THC) using a cocktail of ABC transport inhibitors","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}